Evidence map›Paper›PMID 35445198›Full record

ReviewMaterials advances2022

Making waves: how ultrasound-targeted drug delivery is changing pharmaceutical approaches.

Lauren J Delaney, Selin Isguven, John R Eisenbrey, Noreen J Hickok, Flemming Forsberg

Abstract readReview
In one paragraph

Review in Materials advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Ultrasound-responsive composite hydrogels: Design rules for spatiotemporally controlled drug delivery.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Targeting Lysosomes for Enhanced Anti-Cancer Therapeutics and Immune Response.International journal of biological sciences · 2026
    Review
  10. Treating venous malformations with nanomedicines.Nanomedicine (London, England) · 2025
    Review
  11. Novel design of 3D printed tumbling microrobots for in vivo targeted drug delivery.Journal of controlled release : official journal of the Controlled Release Society · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lauren J DelaneyDepartment of Radiology, Thomas Jefferson University 132 S. 10th Street, Main 763 Philadelphia PA 19107 USA flemming.forsberg@jefferson.edu +1 (215) 955-4870.ORCID https://orcid.org/0000-0001-6794-9550
Selin IsguvenDepartment of Radiology, Thomas Jefferson University 132 S. 10th Street, Main 763 Philadelphia PA 19107 USA flemming.forsberg@jefferson.edu +1 (215) 955-4870.ORCID https://orcid.org/0000-0003-2277-0439
John R EisenbreyDepartment of Radiology, Thomas Jefferson University 132 S. 10th Street, Main 763 Philadelphia PA 19107 USA flemming.forsberg@jefferson.edu +1 (215) 955-4870.ORCID https://orcid.org/0000-0001-6411-3424
Noreen J HickokDepartment of Orthopaedic Surgery, Thomas Jefferson University, 1015 Walnut Street Philadelphia PA 19107 USA.ORCID https://orcid.org/0000-0001-8501-2817
Flemming ForsbergDepartment of Radiology, Thomas Jefferson University 132 S. 10th Street, Main 763 Philadelphia PA 19107 USA flemming.forsberg@jefferson.edu +1 (215) 955-4870.ORCID https://orcid.org/0000-0003-2215-1371

Funding

Preventing Spinal Infection: Ultrasound Triggered ProphylaxisR01AR069119 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI Flemming Forsberg, Noreen J Hickok · 2016 to 2026
$3.2M
Optimizing Ultrasound Enhanced Delivery of TherapeuticsR01CA199646 · NCI · THOMAS JEFFERSON UNIVERSITY · PI FORSBERG, FLEMMING · 2016 to 2023
$2.9M
Synovial Fluid and Joint SepsisR01AR072513 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI HICKOK, NOREEN J · 2017 to 2021
$2.5M
Clinically Translatable Ultrasound-Sensitive Microbubble Approaches for Overcoming Tumor HypoxiaR01EB026881 · NIBIB · THOMAS JEFFERSON UNIVERSITY · PI EISENBREY, JOHN, WHEATLEY, MARGARET A. · 2018 to 2021
$2.5M
Ultrasound-Triggered Prophylaxis as a Novel Paradigm for Preventing Spinal InfectionR00AR078354 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI DELANEY, LAUREN JO · 2022 to 2024
$740k
Ultrasound-Triggered Prophylaxis as a Novel Paradigm for Preventing Spinal InfectionF32AR072491 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI DELANEY, LAUREN JO · 2018 to 2021
$189k
Ultrasound-Sensitive Prophylaxis for Prevention of Post-Operative Infection in Spinal Fusion SurgeryK99AR078354 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI DELANEY, LAUREN JO · 2021 to 2021
$86k
NCI NIH HHS R01 CA199646NIAMS NIH HHS F32 AR072491NIAMS NIH HHS K99 AR078354NIAMS NIH HHS R00 AR078354NIAMS NIH HHS R01 AR069119NIAMS NIH HHS R01 AR072513NIBIB NIH HHS R01 EB026881
6 · The paper itself

Abstract

Administration of drugs through oral and intravenous routes is a mainstay of modern medicine, but this approach suffers from limitations associated with off-target side effects and narrow therapeutic windows. It is often apparent that a controlled delivery of drugs, either localized to a specific site or during a specific time, can increase efficacy and bypass problems with systemic toxicity and insufficient local availability. To overcome some of these issues, local delivery systems have been devised, but most are still restricted in terms of elution kinetics, duration, and temporal control. Ultrasound-targeted drug delivery offers a powerful approach to increase delivery, therapeutic efficacy, and temporal release of drugs ranging from chemotherapeutics to antibiotics. The use of ultrasound can focus on increasing tissue sensitivity to the drug or actually be a critical component of the drug delivery. The high spatial and temporal resolution of ultrasound enables precise location, targeting, and timing of drug delivery and tissue sensitization. Thus, this noninvasive, non-ionizing, and relatively inexpensive modality makes the implementation of ultrasound-mediated drug delivery a powerful method that can be readily translated into the clinical arena. This review covers key concepts and areas applied in the design of different ultrasound-mediated drug delivery systems across a variety of clinical applications.

Identifiers

PMID35445198
PMCPMC8978185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.